FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1046 April 8, 1993 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: The report by Wiggins and colleagues (Nov. 12 issue)¹ provides valuable information on the psychological outcomes of persons undergoing presymptomatic DNA testing for Huntington's disease. One important issue is not addressed, presumably because it is of little consequence in Canada: the problem of cost. At our institution, this testing, including laboratory analysis and necessary genetic and psychological counseling, frequently costs people more than $2,500. Persons at risk for Huntington's disease often feel obligated to meet this expense from their personal funds because they are reluctant to let insurance companies and employers gain access to the results. Hence, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.